Managing female sexual dysfunction.
Managing female sexual dysfunction.
复制标题
DOI：
10.1016/j.urolonc.2021.06.006
复制
发表时间：
2022-08
期刊：
影响因子：
--
通讯作者：
Shelby RA
中科院分区：
文献类型：
--
作者：
Arthur SS;Dorfman CS;Massa LA;Shelby RA
概述女性泌尿系统癌症患者的性功能障碍，评估性问题的方法，以及治疗该患者人群性功能障碍的干预措施。对泌尿系肿瘤学的文献进行了回顾。对其他女性盆腔癌的研究与类似的治疗也进行了审查。性健康是妇女生活质量的一个重要因素，但往往没有得到讨论，问题也没有得到解决。泌尿系统癌症治疗通常导致性功能障碍（例如，性交困难、阴道干燥、性高潮问题），尽管需要更多的研究来了解非手术治疗的影响（例如，放射、化学疗法、免疫疗法）。因此，提供者团队应在治疗期间和治疗后完成必要的性功能障碍筛查。5A模型（即，询问、建议、评估、协助、安排随访）为在筛查过程中与患者沟通和解决性健康问题提供了有用的指南。如果确定需要转诊进行性功能障碍的进一步评估和治疗，则可以使用一些非药物（例如，骨盆底物理治疗;性心理咨询）和药物治疗方法是可用的。性功能障碍在女性泌尿系统癌症幸存者中很常见。常规评估和适当的转诊对于高质量的患者护理至关重要。
Provide an overview of sexual dysfunction in female urologic cancer patients, approaches for assessing sexual problems, and interventions to treat sexual dysfunction in this patient population. A review of the literature in urologic oncology was conducted. Research on other female pelvic cancers with similar treatments was also reviewed. Sexual health is an important element of women’s quality of life that is often not discussed and problems remain unaddressed. Urologic cancer treatments commonly result in sexual dysfunction (e.g., dyspareunia, vaginal dryness, problems with orgasm) in female patients, although more research is necessary to understand the impact of non-surgical treatments (e.g., radiation, chemotherapy, immunotherapy). As such, provider teams should complete necessary screening for sexual dysfunction during and after treatment. The 5 A’s model (i.e., Ask, Advise, Assess, Assist, Arrange Follow-Up) provides a helpful guide for communicating about and addressing sexual health concerns with patients during the screening process. If it is determined that referral for further assessment and treatment of sexual dysfunction is needed, a number of non-pharmacologic (e.g., pelvic floor physical therapy; psychosexual counseling) and pharmacologic treatment approaches are available. Sexual dysfunction is common in female urologic cancer survivors. Routine assessment and appropriate referral are essential for high quality patient care.
登录
查看更多内容
DOI：
10.1016/j.ijrobp.2010.02.058
发表时间：
2011-07-01
影响因子：
7
作者：
Friedman, Lois C.;Abdallah, Rita;Kunos, Charles A.
通讯作者：
Kunos, Charles A.
影响因子：
6.2
作者：
Jensen, PT;Groenvold, M;Machin, D
通讯作者：
Machin, D
影响因子：
6.7
作者：
Falk, Sandy J.;Dizon, Don S.
通讯作者：
Dizon, Don S.
影响因子：
3.8
作者：
Brotto, Lori A.;Heiman, Julia R.;Van Blaricom, Amy
通讯作者：
Van Blaricom, Amy
DOI：
10.1097/gme.0000000000001121
发表时间：
2018-06-01
影响因子：
2.7
作者：
Faubion, Stephanie S.;Larkin, Lisa C.;Kingsberg, Sheryl A.
通讯作者：
Kingsberg, Sheryl A.